NASDAQ:AFMD - Affimed News Headlines

$3.59
+0.22 (+6.53 %)
(As of 09/18/2019 06:00 AM ET)
Today's Range
$3.30
Now: $3.59
$3.5950
50-Day Range
$2.67
MA: $2.86
$3.54
52-Week Range
$2.52
Now: $3.59
$5.08
Volume1.20 million shs
Average Volume379,434 shs
Market Capitalization$223.98 million
P/E RatioN/A
Dividend YieldN/A
Beta2.85

Headlines

Affimed (NASDAQ AFMD) News Headlines

Source:
DateHeadline
Affimed NV (NASDAQ:AFMD) Given Consensus Rating of "Buy" by BrokeragesAffimed NV (NASDAQ:AFMD) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - September 10 at 2:34 AM
Affimed NV (NASDAQ:AFMD) Expected to Announce Quarterly Sales of $6.77 MillionAffimed NV (NASDAQ:AFMD) Expected to Announce Quarterly Sales of $6.77 Million
www.americanbankingnews.com - September 6 at 1:37 AM
Is Affimed (NASDAQ:AFMD) Using Debt Sensibly? - Yahoo FinanceIs Affimed (NASDAQ:AFMD) Using Debt Sensibly? - Yahoo Finance
finance.yahoo.com - September 5 at 11:42 AM
Is Affimed (NASDAQ:AFMD) Using Debt Sensibly?Is Affimed (NASDAQ:AFMD) Using Debt Sensibly?
finance.yahoo.com - September 5 at 11:42 AM
Zacks: Brokerages Anticipate Affimed NV (NASDAQ:AFMD) Will Announce Earnings of -$0.17 Per ShareZacks: Brokerages Anticipate Affimed NV (NASDAQ:AFMD) Will Announce Earnings of -$0.17 Per Share
www.americanbankingnews.com - September 4 at 10:33 PM
Affimed to Participate in Investor Conferences in September - GlobeNewswireAffimed to Participate in Investor Conferences in September - GlobeNewswire
www.globenewswire.com - August 28 at 11:07 AM
Affimed N.V. (AFMD) Q2 2019 Earnings Call Transcript - Yahoo FinanceAffimed N.V. (AFMD) Q2 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - August 11 at 9:43 AM
Affimed N.V. (AFMD) Q2 2019 Earnings Call Transcript - Yahoo Finance AustraliaAffimed N.V. (AFMD) Q2 2019 Earnings Call Transcript - Yahoo Finance Australia
au.finance.yahoo.com - August 10 at 9:44 AM
Affimed N.V. (AFMD) Q2 2019 Earnings Call TranscriptAffimed N.V. (AFMD) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 10 at 9:44 AM
Edited Transcript of AFMD earnings conference call or presentation 7-Aug-19 12:30pm GMT - Yahoo FinanceEdited Transcript of AFMD earnings conference call or presentation 7-Aug-19 12:30pm GMT - Yahoo Finance
finance.yahoo.com - August 9 at 7:18 PM
Affimed EPS misses by €0.03, misses on revenue - Seeking AlphaAffimed EPS misses by €0.03, misses on revenue - Seeking Alpha
seekingalpha.com - August 8 at 12:11 AM
Edited Transcript of AFMD earnings conference call or presentation 7-Aug-19 12:30pm GMTEdited Transcript of AFMD earnings conference call or presentation 7-Aug-19 12:30pm GMT
finance.yahoo.com - August 8 at 12:11 AM
Affimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceAffimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - August 7 at 7:11 PM
Affimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue EstimatesAffimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 7 at 7:11 PM
Affimed Reports Second Quarter 2019 Financial and Operational Results - GlobeNewswireAffimed Reports Second Quarter 2019 Financial and Operational Results - GlobeNewswire
www.globenewswire.com - August 7 at 8:55 AM
Affimed Reports Second Quarter 2019 Financial and Operational ResultsAffimed Reports Second Quarter 2019 Financial and Operational Results
finance.yahoo.com - August 7 at 8:55 AM
Earnings Outlook For Affimed - BenzingaEarnings Outlook For Affimed - Benzinga
www.benzinga.com - August 6 at 7:07 PM
Earnings Outlook For AffimedEarnings Outlook For Affimed
finance.yahoo.com - August 6 at 7:06 PM
Affimed: Put This Company On Your Watch ListAffimed: Put This Company On Your Watch List
seekingalpha.com - August 1 at 7:11 PM
Affimed (AFMD) Presents At 2019 Wells Fargo Biotech Corporate Access Day - SlideshowAffimed (AFMD) Presents At 2019 Wells Fargo Biotech Corporate Access Day - Slideshow
seekingalpha.com - July 31 at 7:01 PM
Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019 - Yahoo FinanceAffimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019 - Yahoo Finance
finance.yahoo.com - July 31 at 8:24 AM
Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019
finance.yahoo.com - July 31 at 8:24 AM
Is Affimed N.V.s (NASDAQ:AFMD) CEO Salary Justified? - Yahoo FinanceIs Affimed N.V.'s (NASDAQ:AFMD) CEO Salary Justified? - Yahoo Finance
finance.yahoo.com - July 18 at 6:00 PM
Is Affimed N.V.'s (NASDAQ:AFMD) CEO Salary Justified?Is Affimed N.V.'s (NASDAQ:AFMD) CEO Salary Justified?
finance.yahoo.com - July 18 at 6:00 PM
Are Natural Killer Cells the Next Big Thing in Immunotherapy? - Yahoo FinanceAre Natural Killer Cells the Next Big Thing in Immunotherapy? - Yahoo Finance
finance.yahoo.com - July 8 at 5:51 PM
All You Need to Know About Affimed N.V. (AFMD) Rating Upgrade to Buy - NasdaqAll You Need to Know About Affimed N.V. (AFMD) Rating Upgrade to Buy - Nasdaq
www.nasdaq.com - July 2 at 5:48 PM
All You Need to Know About Affimed N.V. (AFMD) Rating Upgrade to BuyAll You Need to Know About Affimed N.V. (AFMD) Rating Upgrade to Buy
finance.yahoo.com - July 2 at 5:48 PM
Affimed Added to the Russell 2000®, 3000® and Microcap Indexes - GlobeNewswireAffimed Added to the Russell 2000®, 3000® and Microcap Indexes - GlobeNewswire
globenewswire.com - July 2 at 9:19 AM
New additions to Russell indexes - Seeking AlphaNew additions to Russell indexes - Seeking Alpha
seekingalpha.com - July 1 at 9:19 AM
Affimed Added to the Russell 2000®, 3000® and Microcap Indexes - Yahoo FinanceAffimed Added to the Russell 2000®, 3000® and Microcap Indexes - Yahoo Finance
finance.yahoo.com - July 1 at 9:19 AM
Affimed Added to the Russell 2000®, 3000® and Microcap IndexesAffimed Added to the Russell 2000®, 3000® and Microcap Indexes
finance.yahoo.com - July 1 at 9:19 AM
Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019 - Yahoo FinanceAffimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019 - Yahoo Finance
finance.yahoo.com - June 26 at 9:28 AM
Microcaps mostly among midday movers - Seeking AlphaMicrocaps mostly among midday movers - Seeking Alpha
seekingalpha.com - June 24 at 5:09 PM
Minerva Neurosciences leads healthcare gainers; Avinger and Affimed among losers - Seeking AlphaMinerva Neurosciences leads healthcare gainers; Avinger and Affimed among losers - Seeking Alpha
seekingalpha.com - June 24 at 5:09 PM
New data on Affimeds lead candidate fails to excite investors, shares down 12% - Seeking AlphaNew data on Affimed's lead candidate fails to excite investors, shares down 12% - Seeking Alpha
seekingalpha.com - June 24 at 5:09 PM
Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019 - GlobeNewswireAffimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019 - GlobeNewswire
globenewswire.com - June 24 at 5:09 PM
Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019
finance.yahoo.com - June 24 at 5:08 PM
Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland - GlobeNewswireAffimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland - GlobeNewswire
globenewswire.com - June 12 at 9:23 PM
Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland - Yahoo FinanceAffimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland - Yahoo Finance
finance.yahoo.com - June 12 at 12:16 PM
Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, SwitzerlandAffimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland
finance.yahoo.com - June 12 at 12:16 PM
Affimed Announces Annual General Meeting of Shareholders - GlobeNewswireAffimed Announces Annual General Meeting of Shareholders - GlobeNewswire
www.globenewswire.com - June 6 at 9:22 AM
Affimed Announces Annual General Meeting of Shareholders - NasdaqAffimed Announces Annual General Meeting of Shareholders - Nasdaq
www.nasdaq.com - June 4 at 6:02 PM
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression TechnologyIcosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
finance.yahoo.com - June 3 at 9:15 AM
Affimed to Present at the Jefferies 2019 Healthcare Conference - Yahoo FinanceAffimed to Present at the Jefferies 2019 Healthcare Conference - Yahoo Finance
finance.yahoo.com - May 29 at 9:19 AM
Affimed to Present at the Jefferies 2019 Healthcare ConferenceAffimed to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 29 at 9:19 AM
Affimed (AFMD) Earnings and Sales Exceed Estimates in Q1 - NasdaqAffimed (AFMD) Earnings and Sales Exceed Estimates in Q1 - Nasdaq
www.nasdaq.com - May 23 at 6:40 PM
Affimed (AFMD) Earnings and Sales Exceed Estimates in Q1Affimed (AFMD) Earnings and Sales Exceed Estimates in Q1
finance.yahoo.com - May 23 at 6:39 PM
Edited Transcript of AFMD earnings conference call or presentation 22-May-19 12:30pm GMTEdited Transcript of AFMD earnings conference call or presentation 22-May-19 12:30pm GMT
finance.yahoo.com - May 23 at 9:20 AM
Affimed N.V. (AFMD) CEO Adi Hoess on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaAffimed N.V. (AFMD) CEO Adi Hoess on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 22 at 6:32 PM
Affimed to end cancer program and focus on innate immunity portfolio, shares slide about 10% - MarketWatchAffimed to end cancer program and focus on innate immunity portfolio, shares slide about 10% - MarketWatch
www.marketwatch.com - May 22 at 9:14 AM
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel